Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 2,300 shares, a decline of 37.8% from the September 30th total of 3,700 shares. Based on an average trading volume of 6,500 shares, the short-interest ratio is currently 0.4 days.
Arkema Trading Down 0.9 %
ARKAY traded down $0.83 during trading on Friday, hitting $87.08. The company's stock had a trading volume of 4,722 shares, compared to its average volume of 4,182. The firm's 50 day moving average price is $91.37 and its 200-day moving average price is $94.48. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.86 and a quick ratio of 1.38. The stock has a market cap of $6.53 billion, a PE ratio of 17.21, a PEG ratio of 0.42 and a beta of 1.27. Arkema has a twelve month low of $84.55 and a twelve month high of $114.15.
Arkema (OTCMKTS:ARKAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The basic materials company reported $2.98 earnings per share for the quarter. Arkema had a return on equity of 8.18% and a net margin of 3.80%. The company had revenue of $2.73 billion during the quarter. On average, analysts expect that Arkema will post 9.09 earnings per share for the current year.
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Recommended Stories
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.